Stock Scorecard

Stock Summary for Talis Biomedical Corp (TLIS) - $7.97 as of 12/9/2023 2:38:28 AM EST

Total Score

12 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for TLIS

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for TLIS

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for TLIS

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for TLIS

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for TLIS

Why Talis Biomedical ( TLIS ) Stock Is Exploding Higher - Talis Biomedical ( NASDAQ:TLIS ) 11/14/2023 5:21:00 PM
Azenta Reports Upbeat Earnings, Joins Talis Biomedical, Sally Beauty And Other Big Stocks Moving Higher On Tuesday - Adaptive Biotechnologies ( NASDAQ:ADPT ) , Accolade ( NASDAQ:ACCD ) 11/14/2023 3:39:00 PM
Talis Biomedical Announces 1-for-15 Reverse Stock Split - Talis Biomedical ( NASDAQ:TLIS ) 7/5/2023 12:00:00 PM
Talis Biomedical Announces 1-for-15 Reverse Stock Split 7/5/2023 12:00:00 PM
Why Advanced Health Intelligence Shares Are Trading Higher By 111%; Here Are 20 Stocks Moving Premarket - Advanced Health ( NASDAQ:AHI ) , Biofrontera ( NASDAQ:BFRI ) 6/21/2023 12:10:00 PM
Amicus Therapeutics ( FOLD ) Reports Q1 Loss, Tops Revenue Estimates 5/10/2023 12:15:00 PM
Halozyme Therapeutics ( HALO ) Q1 Earnings and Revenues Miss Estimates 5/9/2023 9:25:00 PM
Talis Biomedical Corporation ( TLIS ) Investor News: Robbins LLP Reminds Investors it is Investigating TLIS on Behalf of Shareholders - Talis Biomedical ( NASDAQ:TLIS ) 5/9/2023 4:43:00 PM
Talis Biomedical to Provide Business Update and Financial Results on May 11, 2023 - Talis Biomedical ( NASDAQ:TLIS ) 5/4/2023 12:00:00 PM
Talis Announces Fourth Quarter and Full Year 2022 Financial Results 3/22/2023 8:05:00 PM

Financial Details for TLIS

Company Overview
Ticker TLIS
Company Name Talis Biomedical Corp
Country USA
Description Talis Biomedical Corporation is a molecular diagnostics company. The company is headquartered in Menlo Park, California.
Sector Name LIFE SCIENCES
Industry Name LABORATORY ANALYTICAL INSTRUMENTS
Most Recent Quarter 9/30/2023
Next Earnings Date N/A

Stock Price History
Last Day Price 7.97
Last Day Price Updated 12/9/2023 2:38:28 AM EST
Last Day Volume 0
Average Daily Volume N/A
52-Week High 9.75
52-Week Low 4.35
Last Price to 52 Week Low 83.22 %

Valuation Measures
Trailing PE N/A
Industry PE 25.19
Sector PE 62.37
5-Year Average PE -2.67
Free Cash Flow Ratio 0.16
Industry Free Cash Flow Ratio 95.51
Sector Free Cash Flow Ratio 31.15
Current Ratio Most Recent Quarter 10.60
Total Cash Per Share 48.32
Book Value Per Share Most Recent Quarter 44.83
Price to Book Ratio 0.18
Industry Price to Book Ratio 802.19
Sector Price to Book Ratio 19.59
Price to Sales Ratio Twelve Trailing Months 6.61
Industry Price to Sales Ratio Twelve Trailing Months 3.48
Sector Price to Sales Ratio Twelve Trailing Months 5.61

Share Statistics
Total Shares Outstanding 1,821,100
Market Capitalization 14,514,167
Institutional Ownership N/A

Dividends
Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Dividend King? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00 %
5-Year Dividend Payments Count 0
Dividend Payout Ratio N/A

Income Statement
Quarterly Earnings Growth YOY 0.00 %
Annual Earnings Growth 41.15 %
Reported EPS 12 Trailing Months -42.42
Reported EPS Past Year -17.58
Reported EPS Prior Year -4.24
Net Income Twelve Trailing Months -75,464,000
Net Income Past Year -113,000,000
Net Income Prior Year -192,000,000
Quarterly Revenue Growth YOY -82.40 %
5-Year Revenue Growth -41.27 %

Balance Sheet
Total Cash Most Recent Quarter 87,996,000
Total Cash Past Year 130,191,000
Total Cash Prior Year 232,545,000
Net Cash Position Most Recent Quarter 87,996,000
Net Cash Position Past Year 130,191,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 126,739,000
Total Stockholder Equity Prior Year 233,977,000
Total Stockholder Equity Most Recent Quarter 81,556,000

Options
Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating None

Technical Analysis
Yahoo Finance Chart Yahoo Finance Chart
MACD 0.58
MACD Signal 0.52
20-Day Bollinger Lower Band 4.34
20-Day Bollinger Middle Band 6.33
20-Day Bollinger Upper Band 8.33
Beta 1.68
RSI 74.41
50-Day SMA 7.21
200-Day SMA 0.00

System
Modified 12/10/2023 12:14:00 AM EST